novo_nordisk_flag

Novo Nordisk halts three haemophilia studies after participants suffer thrombotic events

March 17, 2020
Manufacturing and Production, Research and Development Novo Nordisk, haemophilia, pharma

Novo Nordisk has moved to temporarily shut down two of its Phase 3 and one of its Phase 2 clinical …

astrazeneca_building_white

Success and failure at Phase 3 for AstraZeneca’s Imfinzi combos in first-line small cell lung cancer

March 17, 2020
Manufacturing and Production, Research and Development AstraZeneca, Cancer, Imfinzi, pharma

AstraZeneca has pulled back the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage …

FDA gives emergency authorisation to first coronavirus tests

March 17, 2020
Manufacturing and Production, Sales and Marketing FDA, Roche, US, coronavirus

The coronavirus crisis in the US has thus far been characterised by a lack of testing within its population. This …

moderna_norwood_plant

Human dosing begins for first US coronavirus vaccine

March 17, 2020
Manufacturing and Production, Research and Development Moderna, Vaccine, coronavirus, pharma

The race to develop a vaccine against the ongoing outbreak of novel coronavirus has stepped up with the news that …

anthony_mancini

Genmab announces newly-created Chief Financial Officer appointment

March 16, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genmab, pharma

Genmab has announced the establishment of the new position of Chief Operating Officer at the company, and has furthermore named …

trump_8566730507_2

Trump tried to solicit US-exclusivity for coronavirus vaccine, report claims

March 16, 2020
Sales and Marketing CureVac, Trump, US, coronavirus, pharma

President Trump has attracted criticism from all sides over his response to the novel coronavirus outbreak; after repeatedly downplaying the …

shutterstock_159488225

Bavencio Phase 3 head and neck cancer trial terminated

March 16, 2020
Research and Development, Sales and Marketing Bavencio, Cancer, EMD Serono, Merck KGaA, Pfizer, trial failure

Merck KGaA, its biopharma division EMD Serono, and Pfizer have announced their decision to terminate their ongoing Phase 3 trial …

prep

NHS England to supply HIV prevention drug PrEP with £16m government investment

March 16, 2020
Manufacturing and Production, Sales and Marketing NHS, NHS England, PrEP HIV, PrEP< HIV, UK, pharma

NHS England is set to fund the availability of pre-exposure prophylaxis (PrEP) for the prevention of HIV for local authorities …

shutterstock

Fosun and BioNTech partner up for coronavirus vaccine development and commercialisation

March 16, 2020
Research and Development, Sales and Marketing BioNTech, coronavirus, fosun, pharma

As the novel coronavirus (COVID-19) outbreak continues to test global leadership, a new partnership has been announced between BioNTech and …

celltrion1

FDA greenlights Celltrion HIV drug manufacturing facility in South Korea

March 16, 2020
Manufacturing and Production, Sales and Marketing FDA, celltrion, coronavirus, pharma

South Korean biopharma firm Celltrion has revealed that one of its key manufacturing facilities has been given the all-clear by …

5378943799_deb47ba367_b

Numerous sporting events suspended across the UK, after staff and players test positive for COVID-19

March 13, 2020
Medical Communications Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus

Sporting events across the UK have been postponed as measures are taken to halt the spread of the coronavirus. Rugby …

shutterstock_38078521

AstraZeneca’s cediranib combo misses main goal in platinum-sensitive relapsed ovarian cancer

March 13, 2020
Medical Communications, Research and Development AstraZeneca, cediranib, lynparza, pharma, trial failure

Newly revealed Phase 3 data has shown that AstraZeneca’s oral vascular endothelial growth factor receptor (VEGFR) inhibitor cediranib, when combined …

Venclyxto combo scores European approval for previously untreated chronic lymphocytic leukaemia

March 13, 2020
Medical Communications, Sales and Marketing AbbVie, European Commission, Roche, Venclyxto, pharma

The European Commission has moved to authorise AbbVie and Roche’s B-cell lymphoma-2 (BCL-2) inhibitor Venclyxto (venetoclax) when used in combination …

Photo by Chatham House

UK Government criticised for not enacting social distancing measures to combat coronavirus

March 13, 2020
Medical Communications Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus

The UK government has come under fire from health experts and former cabinet ministers for its strategy in fighting the …

merck-keytruda

Keytruda rejected for NHS use for bladder cancer, will be removed from the Cancer Drugs Fund

March 12, 2020
Sales and Marketing Cancer, Kidney cancer, MSD, NHS, NICE, blader cancer, keytruda, pharma

MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has been knocked back by NICE for use on the NHS as a treatment for …

7424861282_ee152c7c60_b

Iran foreign ministry accuses US of blocking medicine deliveries

March 12, 2020
Business Services Iran, Iran Trump, Trump Iran

A spokesperson from the Iranian foreign ministry has accused the US of refusing to deliver medicine to the country. US …

46451130962_d151b497d6_b

Trump suspends all travel from Europe to US as coronavirus continues to spread

March 12, 2020
Business Services American coronavirus, Chinese Coronavirus, UK Coronavirus, US Coronavirus, Wuhan Coronavirus, wuhan coronavirus.

Last night, President Donald Trump announced significant measures to deal with the increasing threat of the coronavirus. From Friday, the …

teva_copy

Teva’s Ajovy becomes first drug of its kind available on NHS for prevention of chronic migraine

March 12, 2020
Sales and Marketing NICE, Teva, ajovy, migraine, pharma

NICE has announced the authorisation of Teva’s anti-CGRP drug Ajovy (fremanezumab) for the prevention of chronic migraine in adult patients …

4353113087_4d19c3a402_b

Bristol-Myers Squibb liver cancer drug combo gets FDA approval

March 12, 2020
Business Services Bristol; Myer Squibb, FDA, FDA BSM, FDA approvals

The FDA announced on Wednesday that it approved Bristol-Myers Squibb’s Opdivo in combination with Yervoy to treat patients with hepatocellular …

The Gateway to Local Adoption Series

Latest content